BIT's 8th Annual International Conference of Antibodies-2016
第八届国际抗体大会
Theme: Accelerating the R&D of Next Generation Antibodies
主题：加速下一代抗体的发展
Time: April 25-28, 2016
时间：2016年4月25-28日
Venue: Dalian, China
地点：中国大连国际会议中心
Website: cuturl('http://www.bitcongress.com/ica2016/default.asp')
Hosting Organizations: Information Research Center of International Talent China State Administration of Foreign Experts Affairs, China Medicinal Biotech Association
主办方：国家外国专家局国外人才信息研究中心 中国医药生物技术协会
Operating Organization:Foreign Experts Databank of SAFEA-Dalian Biotechnological and Medical Experts Subdivision, BIT Congress Inc., China
承办方：百奥泰国际会议（大连）有限公司 中国外国专家局生物和医药专家外国专家数据库大连分部
Supporting Organization:China Council for the Promotion of International Trade Dalian Sub-Council
支持单位：中国国际贸易促进委员会大连市分会
Program Layout：
Cluster 1: Main Conference
Opening Ceremony and Keynote Forum
Track 1 Global Antibody Market Trend, Business and Partnering
Track 1-1 Promising Future and Challenge, Business and Cooperation in World Antibody Market
Track 1-2 Industry Aspects, Policy, Regulation, IP Issues, Business and Trends in Antibody Market
Track 1-3 IP Issues
Cluster 2: Scientific Program
Track 2 New Technologies and Trends in Antibody Research
Track 2-1: Novel Research in Immune System, Immunology and Immunogenicity of Antibodies
Track 2-2: Immunoglobulin Diversity, Antibody Characterization Technologies and Structure Biology
Track 2-3: Novel Antibody Library Technologies and Microarray Technologies, Nanotechnology, Biochips, Phage Display Technologies for Antibody Research
Track 2-4: Enabled High Throughput/Content Technologies for Antibody Research - From Antibody Screening, Selection to Optimization Technologies
Track 2-5: Antibody Humanization Technologies
Track 2-6: Exploiting the Immune System and Immunotherapeutic Strategies – from Vaccines to Cell-based and Protein Immunotherapy
Track 2-7: Glycoengineered Antibodies, Agonist and Super-agonist Antibodies
Track 2-8: Monovalent, Multivalent Antibodies, Fragments, Single-domain Antibody, and scFv
Track 3 Advances in Antibody Drug and Therapy
Track 3-1: Challenges and New Opportunities with Antibody and Protein Drugs
Track 3-2: Innovative Antibody drugs in Clinical Trail and Development
Track 3-3: Novel Antibody and Biologic Drug Targets
Track 3-4: Antibody-drug Conjugate (ADC) Discovery and Development
Track 3-5: Bispecific and Multispecific antibody discovery and development
Track 3-6: Next Generation of Cancer Immune therapy and Anti-Cancer Antibody
Track 3-7: Novel Therapeutic Antibodies for Infectious and Inflammatory Diseases
Track 3-8: Novel Therapeutic Antibodies for Allergy, Asthma and Autoimmune Diseases
Track 3-9: Antibodies for Pediatrics Diseases
Track 3-10: Therapeutic Antibodies for Neurological Disease and other Neglected Diseases
Track 4 Antibody Applications in Medical Diagnosis and other Non-Medical Field
Track 4-1: Novel Antibodies in Medical Treatment and Diagnosis
Track 4-2: Biomarker Development - Correlating with Antibody
Track 4-3: Antibodies for Immunohistochemistry and Immunofluorescence
Track 4-4: Antibody for Western Blot Analyses, ELISA and ELISPOT Techniques
Track 4-5: Antibody Research in Agriculture, Aquaculture, Veterinary and Food Sciences
Track 5 Antibody Design, Engineering and Production
Track 5-1: Analytical Strategies for Early Phase Protein Engineering and New Antibody Formats
Track 5-2: Advances in Antibody Engineering and Design Strategies
Track 5-3: Cell Line and Model Organisms Development for Antibodies
Track 5-4: Novel Upstream Bioprocess Technologies in Antibody Production
Track 5-5: Optimised Platform for Downstream Processing of Antibodies
Track 5-6: Improved Purification and Modification Methods for Antibody Fragments
Track 5-7: Novel Expressing Platform for Antibody Production
Track 5-8: Biosimilars and Biobetters - Methods and Protocols
Highlights of the ICA-2016
1,000+ Attendees Coming from All over the World to Exchange Ideas, Build New Networks, and Foster Friendships
200+ Oral Presentations Covering the Hot Topics and Cutting-edge Technology in the Field of Antibody
80+ Exhibitors and 30+ Posters Showcasing the Emerging New Products and Technologies
Social Activities and Networking, Field Trip and Tech-tour, Build Partnerships, Find Huge Opportunities and Markets for Your Business over the World
Antibodies are multi-faceted proteins, capable of an extraordinary array of important functions. Not only major players in protection against invading pathogens, they play critical roles in inflammatory and autoimmune diseases, their induction is central to many vaccine strategies, and they are an unrivalled platform for engineering highly effective diagnostic and therapeutic reagents. The 2016 ICA will present in-depth coverage of recent advances in this exciting field, in an informal setting designed for maximal interaction. Bringing together academic researchers with their colleagues in the biopharma industry, it will provide an ideal opportunity for leading researchers from around the world to present and discuss cutting-edge data.
Fusing new developments in basic science with high-impact translational and clinical research, the meeting will provide a stimulating program featuring an international mix of established and upcoming researchers. A key emphasis will be on mechanisms of antibody action in health and disease and the application of this mechanistic understanding to the design of improved vaccines and monoclonal antibody therapeutics. Topics will mainly cover antibody market and business, antibody discovery and technology, Medical and Non-medical Applications of Antibodies, Antibody Engineering, and Production. Building on the highly creative, congenial academia-industry interactions that characterized the previous meetings in this series, the conference will provide the ideal setting for cross-fertilization of ideas, conceptual advances, and the promotion of synergistic collaborations.
We sincerely look forward to your participation of the conference in China. Please do not hesitate to contact me for any further assistance.
Keynote speakers:
Dr. Patrick Liu, Vice President, Teva Pharmaceuticals Ltd., USA
Dr. Jose de Chastonay, Chief Marketing Officer, Bachem Holding AG, Switzerland
Dr. Vadim T. Ivanov, Director and Professor, Russian Academy of Sciences, Russia
Dr. Zhenping Zhu, Executive Vice President, Biologics President & CEO, Kadmon China, USA
For more information of this event, please visit: cuturl('http://www.bitcongress.com/ica2016/default.asp')
Thank you for your time. I look forward to your reply.
Sincerely yours,
Ms. Jenny Kang
Email:
jenny@bitcongress.com
Organizing Committee of ICA-2016
East Area, F11, Building 1,
Dalian Ascendas IT Park,
1 Hui Xian Yuan,
Dalian Hi-tech Industrial Zone,
LN 116025, China
Tel: 0086-411-84799609 ext 842
Fax: 0086-411-84799629
